EP1718322
Samverkandi samsetning með FK-228.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.2.2005EP published:
13.7.2011EP application number:
05719967.1
EP translation filed:
19.8.2011Grant published:
15.9.2011EPO information:
European Patent Register
Max expiry date:
24.2.2025Expiry date:
24.2.2021
Title:
SYNERGISTIC COMPOSITIONS WITH FK-228
Timeline
Today
25.2.2005EP application
13.7.2011EP Publication
19.8.2011Translation submitted
15.9.2011Registration published
24.2.2021Expires
Owner
Name:
Astellas Pharma Inc.Address:
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, 1038411, Tokyo, JP
Inventor
Name:
NAOE, YoshinoriAddress:
Yokohama-shi, Kanagawa, JP
Name:
INOUE, Takeshic/o Astellas Pharma IncAddress:
Chuo-ku, Tokyo, JP
Name:
KANO, Yasuhikoc/o Tochigi Cancer CenterAddress:
Utsunomiya-shi, Tochigi, JP
Agent
Name:
Reynaldsson Patent ConsultingAddress:
Pósthólf 48, 212, Garðabæ,
Priority
Number:
2004050520Date:
25.2.2004Country:
JP
Number:
566077 PDate:
29.4.2004Country:
US
Classification
Categories:
A61K 38/15, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 5.1.2012
Expires: 24.2.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 7.1.2013
Expires: 24.2.2014
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 9.1.2014
Expires: 24.2.2015
Payer: Árnason Faktor
Number: 11
Paid: 6.1.2015
Expires: 24.2.2016
Payer: Árnason Faktor
Number: 12
Paid: 5.1.2016
Expires: 24.2.2017
Payer: Árnason Faktor
Number: 13
Paid: 9.1.2017
Expires: 24.2.2018
Payer: Árnason Faktor
Number: 14
Paid: 8.1.2018
Expires: 24.2.2019
Payer: Árnason Faktor
Number: 15
Paid: 9.1.2019
Expires: 24.2.2020
Payer: Árnason Faktor
Number: 16
Paid: 14.1.2020
Expires: 24.2.2021
Payer: Árnason Faktor ehf.